Lateral ulnar collateral ligament reconstruction using an autologous triceps tendon graft for subclinical posterolateral rotatory instability in recalcitrant lateral epicondylitis.


Journal

Journal of shoulder and elbow surgery
ISSN: 1532-6500
Titre abrégé: J Shoulder Elbow Surg
Pays: United States
ID NLM: 9206499

Informations de publication

Date de publication:
Jun 2023
Historique:
received: 12 10 2022
revised: 30 01 2023
accepted: 05 02 2023
medline: 19 5 2023
pubmed: 14 3 2023
entrez: 13 3 2023
Statut: ppublish

Résumé

To evaluate midterm outcome of lateral ulnar collateral ligament (LUCL) repair with triceps autograft in patients with PLRI under recalcitrant lateral epicondylitis. In total, 25 elbows (23 patients) with recalcitrant epicondylitis longer than 12 months were included into this retrospective study. All patients underwent arthroscopic instability examination. In 18 elbows (16 patients, mean age 47.4 years, range 25-60), PLRI was verified, and an LUCL repair using an autologous triceps tendon graft was performed. Clinical outcome was evaluated before and at least 3 years after surgery using the American Shoulder and Elbow Surgeons Standardized Shoulder Assessment Form-Elbow Score (ASES-E), Liverpool Elbow Score (LES), Mayo Elbow Performance Index (MEPI), Patient-Rated Elbow Evaluation score (PREE), Subjective Elbow Value (SEV), quick Disabilities of the Arm, Shoulder, and Hand score (qDASH), and the visual analog scale (VAS) for pain. Postoperative satisfaction with the procedure and complications were recorded. Seventeen patients were available at a mean follow-up of 66.4 months (range 48-81). Patient satisfaction postoperatively was reported in 15 elbows as excellent (90%-100%) and 2 as moderate, with 93.1% overall. All scores of the 3 female and 12 male patients significantly increased from pre- to the postoperative follow-up (ASES: 28.3 ± 10.7 to 54.6 ± 12.1, P < .001; MEPI: 49.2 ± 8.3 to 90.5 ± 15.4, P < .001; PREE: 66.1 ± 14.9 to 11.3 ± 23.5, P < .001; qDASH: 63.2 ± 21.1 to 11.5 ± 22.6, P < .001; VAS: 8.75 ± 1.0 to 1.5 ± 2.0, P < .001). All patients suffered from high extension pain preoperatively, which was reported to be relieved after surgery. No recurrent instability or major complication occurred. The repair and augmentation of the LUCL with a triceps tendon autograft reached significant improvements; hence, it seems to be a good treatment option for posterolateral elbow rotatory instability with promising midterm results under a low rate of recurrent instability.

Identifiants

pubmed: 36914048
pii: S1058-2746(23)00258-6
doi: 10.1016/j.jse.2023.02.123
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1262-1270

Informations de copyright

Copyright © 2023 Journal of Shoulder and Elbow Surgery Board of Trustees. Published by Elsevier Inc. All rights reserved.

Auteurs

Martin Eigenschink (M)

II Orthopedic Department, Sacred Heart of Jesus, Vienna, Austria; Austrian Research Group for Regenerative and Orthopedic Medicine (AURROM), Vienna, Austria; AUVA Trauma Center Vienna-Meidling, Vienna, Austria.

Leo Pauzenberger (L)

II Orthopedic Department, Sacred Heart of Jesus, Vienna, Austria; Health Pi Medical Center, Vienna, Austria; Austrian Research Group for Regenerative and Orthopedic Medicine (AURROM), Vienna, Austria.

Brenda Laky (B)

Austrian Research Group for Regenerative and Orthopedic Medicine (AURROM), Vienna, Austria.

Roman C Ostermann (RC)

II Orthopedic Department, Sacred Heart of Jesus, Vienna, Austria; Austrian Research Group for Regenerative and Orthopedic Medicine (AURROM), Vienna, Austria.

Werner Anderl (W)

Austrian Research Group for Regenerative and Orthopedic Medicine (AURROM), Vienna, Austria.

Philipp R Heuberer (PR)

Schulterzentrum Wien, Vienna, Austria; Health Pi Medical Center, Vienna, Austria; Austrian Research Group for Regenerative and Orthopedic Medicine (AURROM), Vienna, Austria. Electronic address: philipp@heuberer.at.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH